Medicare patients with multiple sclerosis bear the burden of rising drug prices

In a decade, Medicare recipients saw a sevenfold increase in out of pocket costs for multiple sclerosis drugs. Spending on these drugs by Medicare itself increased by tenfold.

Leave a Reply

Your email address will not be published. Required fields are marked *